Supervivencia a 5 años por grupo de riesgo de pacientes con cáncer invasivo de próstata diagnosticado en el instituto del Cáncer SOLCA Loja durante julio 2009 a diciembre 2010

Abstract

The objective is to determine the 5-year survival for risk groups in patients with prostate cancer. This is a descriptive, retrospective and cross-sectional study included 62 patients treated for prostate cancer in SOLCA Loja. Whose hypothesis show as it increases the risk group the survival rate decreases. It is noted that in patients with a high risk group the survival rate decreases, so we have that low-risk patients had a survival of 64%, the intermediate risk 66%, the high-risk 72% and risk very high 40%. Overall survival is inversely proportional to the risk group. Respecting at the survival obtained by the Kaplan Meier method shows that as clinical stage progresses the percentage survival decreases, finding a 64% in low risk, 66% at intermediate risk, a 72% at high risk and 40% at risk very high.